Allspring Global Investments
XGN icon

Allspring Global Investments’s Exagen XGN Stock Holding History

Allspring Global Investments’s Portfolio XGN Stock Details XGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-5,245
Closed -$42K – 2958
2022
Q1 		$42K Buy
5,245
+2,229
+74% +$19.2K ﹤0.01% 2867
2021
Q4 		$35K Buy
+3,016
New +$35.3K ﹤0.01% 2873

Other funds holding XGN

CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Allspring Global Investments's XGN Position: Q2 2022 in Review

Allspring Global Investments sold out of Exagen (XGN) in Q2 2022, closing a stake of 5,245 shares — an estimated $42K sold.

Allspring Global Investments first reported a position in XGN in Q4 2021 and held it in 2 quarters. The position peaked at $42K in Q1 2022. 47 funds tracked by Wall St. Rank hold XGN as of Q2 2022.

  • Allspring Global Investments reported no remaining Exagen position as of Q2 2022 after selling out during the quarter.
  • Allspring Global Investments sold 5,245 Exagen shares in Q2 2022, an estimated $42K.
  • Allspring Global Investments first reported a position in Exagen in Q4 2021 and held it in 2 quarters.
  • Allspring Global Investments's Exagen position peaked at $42K in Q1 2022.
  • 47 funds tracked by Wall St. Rank held Exagen as of Q2 2022.

Based on Allspring Global Investments's 13F filing for Q2 2022, filed 25 Jul 2022.